NCT06888843View on ClinicalTrials.gov

Study to Evaluate the Use of Capecitabine in Monotherapy and in Combination With Oxaliplatin in Elderly Patients as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer.

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 1, 2028

Study Completion Date

February 1, 2028

Conditions
Colorectal Cancer
Interventions
DRUG

Capecitabine

Capecitabine 2000mg/m2 from day 1 to 14

DRUG

Oxaliplatin

Oxaliplatin 130mg/m2 on day 1, cycle of 21 days

Trial Locations (1)

603126

RECRUITING

"Research Institute of Clinical Oncology Nizhny Novgorod Regional Clinical Oncological Dispensary", Nizhny Novgorod

All Listed Sponsors
lead

Nizhny Novgorod Regional Clinical Oncology Center

OTHER_GOV